Eve Air Mobility just flew its eVTOL for Brazil’s top officials. Is this the moment the air taxi race gets real?
Merck’s $6.7bn Terns Pharmaceuticals buy puts CML drug TERN-701 in play as Keytruda patent cliff nears
Read More 6 minute read Pharma Industry News What rademikibart Phase 3 data could mean for Connect Biopharma’s immunology strategy (NASDAQ: CNTB) Connect Biopharma’s rademikibart Phase 3 eczema data will debut at AAD 2026. Discover what it means for biologic competition and Connect Biopharma strategy. bySoujanya RaviMarch 13, 2026